Amplified Sciences Earns CLIA Certification for Its First Test to Assess Pancreatic Cancer Risk
February 19, 2025
February 19, 2025
WEST LAFAYETTE, Indiana, Feb. 19 -- Purdue University issued the following news release:
* * *
Amplified Sciences earns CLIA certification for its first test to assess pancreatic cancer risk
Company to commercialize PanCystPro, including establishing an early access program and completing a clinical utility trial in 2025
WEST LAFAYETTE, Ind. -- Amplified Sciences, a clinical-stage life sciences diagnostic company that develops tests for early, . . .
* * *
Amplified Sciences earns CLIA certification for its first test to assess pancreatic cancer risk
Company to commercialize PanCystPro, including establishing an early access program and completing a clinical utility trial in 2025
WEST LAFAYETTE, Ind. -- Amplified Sciences, a clinical-stage life sciences diagnostic company that develops tests for early, . . .